Prosecution Insights
Last updated: August 15, 2026

Intervet Inc.

21 pending office actions • 9 art units • 19 examiners • 0 of 21 (0%) have an AI response strategy ready • 32 patents granted in the last 365 days

Portfolio Summary

21
Total Pending OAs
14
Non-Final OAs
5
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (38%)
9
Medium (43%)
4
Easy (19%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (5%)
§103 only5 (24%)
§112 only3 (14%)
Double-patenting only1 (5%)
Double-patenting + other4 (19%)
Multi-statute (no §101)7 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

14
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
10% of docket
5
Business / Other
24% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

210 h
Manual time on pending OAs
42 h
Time saved (low, 20%)
74 h
Time saved (mid, 35%)
1.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SIFFORD, JEFFREY MARK 2 55.7% +32.1%
DICKENS, AMELIA NICOLE 2 47.2% +22.4%
GANGLE, BRIAN J 1 76.6% +15.2%
BOESEN, AGNIESZKA 1 68.3% +22.0%
SALVOZA, M FRANCO G 1 68.7% +29.6%
CHESTNUT, BARRY A 1 73.4% +6.3%
MAHADEVAN, JANAKI ANANTH 1
JACKSON-TONGUE, LAKIA J 1 68.8% +20.8%
DUFFY, PATRICIA ANN 1 52.7% +34.2%
WINAKUR, ERIC FRANK 1 79.2% +13.8%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18290819 SYSTEM AND METHOD FOR PREDICTING ILLNESS, DEATH AND/OR OTHER ABNORMAL CONDITION OF AN ANIMAL WINAKUR, ERIC FRANK 31d overdue
18257600 CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS KIM, YUNSOO 15d overdue
18293378 A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES JACKSON-TONGUE, LAKIA J
18570326 PALATABLE VETERINARY COMPOSITIONS SEITZ, ANTHONY JOSEPH
18252624 RECOMBINANT VECTORS ENCODING CHIMERIC CORONAVIRUS SPIKE PROTEINS AND USE THEREOF SIFFORD, JEFFREY MARK
18313759 ANTIBODIES AGAINST CANINE PD-1 MOSELEY II, NELSON B
17775428 NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS DICKENS, AMELIA NICOLE
17775425 A NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS DICKENS, AMELIA NICOLE

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18290819 SYSTEM AND METHOD FOR PREDICTING ILLNESS, DEATH AND/OR OTHER ABNORMAL CONDITION OF AN ANIMAL WINAKUR, ERIC FRANK 31d overdue
18293007 A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES DUFFY, PATRICIA ANN 8d overdue
19094116 CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS GANGLE, BRIAN J
18723259 STABILISED LIQUID VACCINES OF LIVE VIRUSES BOESEN, AGNIESZKA
18643377 RABIES VIRUS VACCINE SALVOZA, M FRANCO G
18684161 METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE SIFFORD, JEFFREY MARK
18293378 A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES JACKSON-TONGUE, LAKIA J
18252624 RECOMBINANT VECTORS ENCODING CHIMERIC CORONAVIRUS SPIKE PROTEINS AND USE THEREOF SIFFORD, JEFFREY MARK

Top Art Units

Art UnitApps
1645 4
1671 3
1641 3
3791 1
1629 1
1624 1
1642 1
1643 1
3683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19094116 CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS GANGLE, BRIAN J §102§103DP Non-Final OA Pending Mar 28, 2025
18723259 STABILISED LIQUID VACCINES OF LIVE VIRUSES BOESEN, AGNIESZKA §103 Non-Final OA Pending Jun 21, 2024
18643377 RABIES VIRUS VACCINE SALVOZA, M FRANCO G §103DP Non-Final OA Pending Apr 23, 2024
18684161 METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE SIFFORD, JEFFREY MARK 1671 §103DP Non-Final OA Pending Feb 15, 2024
18683835 METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE CHESTNUT, BARRY A §102§103DP Non-Final OA Pending Feb 15, 2024
18294592 METHOD OF TREATING VETERINARY VIRAL DISEASES MAHADEVAN, JANAKI ANANTH §103 Non-Final OA Pending Feb 02, 2024
18293378 A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES JACKSON-TONGUE, LAKIA J 1645 §102§112Other Non-Final OA Pending Jan 30, 2024
18293007 A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES DUFFY, PATRICIA ANN 1645 §112Other Final Rejection 8d overdue Pending Jan 29, 2024
18290819 SYSTEM AND METHOD FOR PREDICTING ILLNESS, DEATH AND/OR OTHER ABNORMAL CONDITION OF AN ANIMAL WINAKUR, ERIC FRANK 3791 §101§102§103§112 Final Rejection 31d overdue Pending Jan 22, 2024
18570326 PALATABLE VETERINARY COMPOSITIONS SEITZ, ANTHONY JOSEPH 1629 §102§103 Non-Final OA Pending Dec 14, 2023
18264446 VACCINATION FOR PROTECTING POULTRY AGAINST A POULTRY PATHOGEN LY, KRISTINA ELISABETH 1641 DP Non-Final OA Pending Aug 07, 2023
18257889 MULTIVALENT HVT VECTOR VACCINE ZOU, NIANXIANG 1671 §103Other Non-Final OA 47d Pending Jun 16, 2023
18335415 SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS BORALSKY, LUKE ALAN 1624 §112Other Non-Final OA 9d overdue Pending Jun 15, 2023
18257600 CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS KIM, YUNSOO 1641 §102§103§112 Final Rejection 15d overdue Pending Jun 15, 2023
18257409 CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS TAYLOR, LIA ELAN 1641 §103 Final Rejection 23d overdue Pending Jun 14, 2023
18252624 RECOMBINANT VECTORS ENCODING CHIMERIC CORONAVIRUS SPIKE PROTEINS AND USE THEREOF SIFFORD, JEFFREY MARK 1671 §103§112 Non-Final OA Pending May 11, 2023
18313759 ANTIBODIES AGAINST CANINE PD-1 MOSELEY II, NELSON B 1642 §102§112Other Non-Final OA Pending May 08, 2023
17819745 PD-L1 ANTIBODIES BINDING CANINE PD-L1 DUFFY, BRADLEY 1643 §112 Final Rejection 12d Pending Aug 15, 2022
17775428 NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS DICKENS, AMELIA NICOLE 1645 §102§112 Non-Final OA Pending May 09, 2022
17775425 A NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS DICKENS, AMELIA NICOLE 1645 §102§112 Non-Final OA Pending May 09, 2022
17632151 System And Method For Determning Status Of Health Of Animals Arriving At A Feed Location WINSTON III, EDWARD B 3683 §103 Non-Final OA 15d overdue Pending Feb 01, 2022

Managing Intervet Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month